← Back to recalls
FDA DrugClass IINotable

FDA Recall: Semaglutide, For Rx compounding use only, packaged in a) 1g, NDC 84385-106-01; b) 5g, NDC 84385-106

Date: 2026-03-11
Brand: Harbin Jixianglong Biotech Co., Ltd.
Category: Drug
FDA Class: Class II

Description

CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before distribution

Hazard

CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before distribution

Remedy

N/A

View original recall →
FDA Recall: Semaglutide, For Rx compounding use only, packaged in a) 1g, NDC 84385-106-01; b) 5g, NDC 84385-106 | RecallWatch